Equashield Equashield Syringe Unit (UDI 07290013484031)Recalls & reported problems
Equashield Medical Ltd · Class 2
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07290013484031), received between Nov 12, 2020 and Mar 16, 2022 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Fluid/Blood Leak” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Fluid/Blood Leak1
- Incomplete or Inadequate Connection1
Patient problems
- Chemical Exposure1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMar 16, 2022Fluid/Blood Leak
EQUASHIELD CLOSED SYSTEM TRANSFER DEVICE, 5ML SYRINGE, LOT 219669A IS LEAKING FROM THE BOTTOM OF THE SYRINGE ONTO EMPLOYEE'S HAND. THERE ISN'T SUPPOSED TO BE LIQUID BENEATH THE PLUNGER. THERE IS LIQUID BENEATH THE PLUNGER AND NOT AIR. FDA SAFETY REPORT ID # (B)(4).
Patient problems: Chemical Exposure
MAUDE report 13798046 ↗MalfunctionNov 12, 2020Incomplete or Inadequate Connection
DEVICE NOT CONNECTING PROPERLY AS IT SHOULD.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 10828701 ↗
Other Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System devices
- BD PhaSeal 515003BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall183 reports
- BD PhaSeal 515056BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall159 reports
- BD PhaSeal Optima 515070BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall154 reports
- Alaris 10012241-0500BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall138 reports
- BD PhaSeal 515005BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall128 reports
- ICU Medical CL3011Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls26 reports
- BD PhaSeal Optima 515052BD Switzerland Sàrl · Closed antineoplastic and hazardous drug reconstitution and transfer system1 recall114 reports
- ICU Medical CL3511Icu Medical, Inc. · Closed antineoplastic and hazardous drug reconstitution and transfer system3 recalls6 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.